Related Experiment Videos

Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis

Akemi Yamamoto1, Yasuyuki Katayama, Koji Tomiyama

  • 1Internal Medicine, The Japan Self-Defense Forces Central Hospital, Tokyo, Japan. User931115@aol.com

Thyroid : Official Journal of the American Thyroid Association
|April 10, 2004
PubMed

Insights

Methimazole (MMI) can cause rare aplastic anemia in Graves' disease patients. This case highlights bone marrow plasmacytosis, suggesting immune mechanisms in MMI-induced aplastic anemia.

Area of Science:

  • Endocrinology
  • Hematology
  • Pharmacology

Background:

  • Graves' disease is an autoimmune disorder treated with methimazole (MMI).
  • Aplastic anemia is a severe, rare adverse effect of MMI therapy.
  • Early identification and management are crucial for patient outcomes.

Observation:

  • A 53-year-old female presented with fever and sore throat after 30 days of MMI treatment.
  • Laboratory results revealed severe leukopenia, granulocytopenia, and thrombocytopenia.
  • Bone marrow aspirates showed hypocellularity with significant plasmacytosis.

Findings:

  • The patient was diagnosed with methimazole-induced aplastic anemia.
  • Peripheral blood counts showed poor recovery despite MMI withdrawal.
  • Bone marrow plasmacytosis was observed, a rare finding in MMI-induced aplastic anemia.

Implications:

  • This case suggests potential immunogenic mechanisms underlying MMI-induced aplastic anemia.
  • Further research into the immunopathology of MMI adverse effects is warranted.
  • Awareness of this rare complication is important for clinicians managing Graves' disease.

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...